The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Indicao Indicado para cavalos atletas em todas as fases de vida
After a clinical evaluation, your provider recommends the right combination from a full range of physician-directed options
How to Inject Semaglutide for Weight Loss Table of Contents: How to Inject GLP-1 For Weight Loss How do GLP-1 Achieve Weight Loss
Even if the liquid appears clear, using medication past its expiration date carries the risk of reduced effectiveness and potential introduction of bacterial growth if the formulation contains a single-use vial without preservatives